Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.5. rezultāts no 100.
377. lappuse
... Calculate the water equivalence of the Karl Fischer reagent as follows : where : e = W VT - VA e = Water equivalence of the Karl Fischer reagent in terms of milligrams of water per milliliter ; W = Milligrams of water ; VT - Milliliters ...
... Calculate the water equivalence of the Karl Fischer reagent as follows : where : e = W VT - VA e = Water equivalence of the Karl Fischer reagent in terms of milligrams of water per milliliter ; W = Milligrams of water ; VT - Milliliters ...
381. lappuse
... Calculate the antibiotic con- tent as described in paragraph ( f ) of this section . ( f ) Calculations ( 1 ) F factor determina- tion . Using the appropriate working standard for the particular antibiotic to be tested , assay the ...
... Calculate the antibiotic con- tent as described in paragraph ( f ) of this section . ( f ) Calculations ( 1 ) F factor determina- tion . Using the appropriate working standard for the particular antibiotic to be tested , assay the ...
395. lappuse
... calculate the drug content using the temperature , instrumental conditions , flow rate , and calculations specified in the monograph for the drug being test- ed . Use a detector sensitivity setting that gives a peak height for the work ...
... calculate the drug content using the temperature , instrumental conditions , flow rate , and calculations specified in the monograph for the drug being test- ed . Use a detector sensitivity setting that gives a peak height for the work ...
396. lappuse
... Calculate either the trailing factor ( T ) , from distances measured along the hor- izontal line at 5 percent of the ... Calculate the number of theoretical plates ( n ) of the column as follows : ( 3 ) Resolution . Calculate the resolu ...
... Calculate either the trailing factor ( T ) , from distances measured along the hor- izontal line at 5 percent of the ... Calculate the number of theoretical plates ( n ) of the column as follows : ( 3 ) Resolution . Calculate the resolu ...
399. lappuse
... Calculate the clindamycin content as directed in paragraph ( f ) of this section . ( f ) Calculations . Calculate the clindamycin content of the sample as follows : Micrograms of clindamycin_R1 × W × ƒ per milligram where : RxW И Ru ...
... Calculate the clindamycin content as directed in paragraph ( f ) of this section . ( f ) Calculations . Calculate the clindamycin content of the sample as follows : Micrograms of clindamycin_R1 × W × ƒ per milligram where : RxW И Ru ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning